Beclomethasone propionate API
[Introduction: Beclomethasone propionate API is a powerful topical glucocorticoid drug with anti-inflammatory, anti-allergic and antipruritic effects./Aluminum can packaging, if you need more information Beclomethasone propionate API manufacturer, beclomethasone propionate API manufacturer, beclomethasone propionate API in stock, where to buy beclomethasone propionate API, beclomethasone propionate API price, beclomethasone propionate API For information on metasone raw powder manufacturers and other information, please call Manager Liu, the product manager of the beclomethasone propionate API manufacturer,】
Aluminum listening small picture
Alias beclomethasone dipropionate beclomethasone chloride Betamethasone dipropionate, beclomethasone, beclomethasone propionate, beclomethasone dipropionate, beclomethasone propionate, beclomethasone propionate
English name
Quality Standard no. Metasone raw material is a renal corticosteroid raw material
It is a powerful external glucocorticoid drug that has anti-inflammatory, anti-allergic and antipruritic effects. It can inhibit bronchial exudates, eliminate bronchial mucosal swelling, and relieve bronchospasm. . It has a far stronger vasoconstrictive effect on the skin than hydrocortisone. The local anti-inflammatory effect is twice that of fluocinolone and triamcinolone. It is highly lipophilic and easy to penetrate. It takes effect within minutes after being applied to the affected area.
It also has no significant effect on body temperature and urination. Therefore, topical application will not inhibit human cortical function and cause adverse reactions caused by cortical dysfunction.
For external use, it can treat various inflammatory skin diseases, such as eczema, allergic dermatitis, neurodermatitis, contact dermatitis, psoriasis, itching, etc. Aerosols can be used for chronic and allergic asthma, allergic rhinitis, etc.
[If you want to inquire about beclomethasone propionate API manufacturer, beclomethasone propionate API manufacturer, beclomethasone propionate API stock, where to buy beclomethasone propionate API, Beclomethasone propionate raw material price, beclomethasone propionate raw powder manufacturers and other information, please call the product manager Liu]
Extended reading Mometasone has smaller risks than beclomethasone in treating asthma. Systemic effects
European and American researchers reported in the journal Chest on October 1 that the use of mometasone furoate to treat asthma appears to cause a significant reduction in serum cortisone concentrations compared with the use of beclomethasone dipropionate. less.
The lead researcher, Ph.D., from the School of Medicine at the University of Athens, Greece, said that topical inhaled corticosteroids have been a new method of asthma treatment. This is because it can achieve therapeutic effects with virtually no systemic effects. However, improvements in treatments continue, and mometasone is a new compound with improved properties.
Drs. and colleagues randomly assigned patients with mild asthma to receive daily mometasone in a dry powder inhaler, daily beclomethasone in a hydrofluorane-fueled metered-dose inhaler, or sub-daily inhalation of a chlorofluorocarbon. Beclomethasone daily. Days later, the mometasone group showed a tendency for higher expiratory flow peaks in the morning and evening. Also, the mean decrease in serum cortisone concentration was significantly smaller compared with the other two groups. There were 1 patient reported adverse reactions in the mometasone group and 1 patient in the other two groups. However, the adverse reactions were mild and no case required immediate interruption of treatment.
The researchers concluded that under these conditions, the mometasone group had a significantly lower effect on the hypothalamic pituitary adrenal axis as judged by serum cortisone concentrations than the two beclomethasone formulations. They also noted that further research is needed to determine whether this benefit persists with long-term treatment.
News